FDA Investigator Tekalign Wondimu
Tekalign Wondimu has inspections in 2 countries as of 19 Oct 2023. Tekalign Wondimu has collaborated with a combinined 1423 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
19 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
United States of America
Co-Investigator(s):
Albert A Salvador,
Amy N Chen,
Anastasia G Lolas,
Anastasia M Shields,
Anita R Michael,
Anthony A Charity,
Audrey Thereset Uy,
CDR John Mastalski,
Christina K Theodorou,
Craig D Zagata,
Daniel J Min,
Daniel W Johnson,
David A Oluwo,
David J Hafner,
Deborah J Parris,
Debra J Bennett,
Debra L Pagano,
Demitria J Xiradakis,
Denise M Digiulio,
Douglas C Kovacs,
Dr. Gerald E Poly,
Elaine E Gilfillan,
Eric Rothschild,
George Pyramides,
Hala L Selby,
Helen Verdel,
James A Liubicich,
James M Mason,
James P Mcevoy,
Jay T Wong,
Johnna L Bleem,
Jose M Cayuela,
Joseph L Despins, PhD,
Juan Rjimenez Garcia,
Juanita P Versace,
Julianne C Mccullough,
Kames A Liubicich,
Karen A Briggs,
Karyn M Campbell,
Kendra L Brooks,
Kristen D Evans,
Kristina J Donohue,
LCDR Susan E Polifko,
Lisa B Orr,
LT John M Mastalski,
Marcellinus D Dordunoo,
Marcus A Ray,
Martha Sullivan Myrick,
Matthew R Noonan,
Meredith L Sheridan,
Michael A Taylor,
Michael D Omeara,
Michael L Casner,
Michael R Klapal,
Mindy M Chou,
Nancy F Scheraga,
Nikisha M Bolden,
Paul L Bellamy,
Philip F Istafanos, DMV, MS,
Prabhu P Raju,
Rachael A Moliver,
Rachael O Oyewole,
Roseline N Boateng,
Satheesh Thomas,
Sena G Dissmeyer,
Sony Mathews,
Stephanie Mangigian, MS/OSH, RN,
Susan F Laska, MS,
Tammy L Chavis,
Tania E Vizcaino,
Tanya R Syffrard,
Thomas E Friel,
Vlada Matusovsky,
William J Leonard,
Yiyue Zhang (nmi), PhD,
Yvonne C Mcknight,
Zhao Wang, PhD,
Zhong Li, PhD
Tekalign Wondimu's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2023 | FDA 483 | Pine Pharmaceuticals, LLC - Form 483, 2023-09-19 |
October, 2021 | EIR | Frontage Laboratories, Inc. - EIR, 2021-10-15 |
June, 2021 | FDA 483 | Granules Pharmaceuticals Inc. - Form 483, 2021-06-25 |
August, 2022 | FDA 483 | ImprimisRx NJ - Form 483, 2022-08-05 |
October, 2021 | FDA 483 Response | Frontage Laboratories, Inc. - Form 483R, 2021-11-04 |
June, 2022 | FDA 483 | Dercher Enterprises, Inc., DBA Gordon Laboratories - Form 483, 2022-06-13 |
May, 2023 | FDA 483 | West Services and Solutions LLC - Form 483, 2023-05-18 |
October, 2021 | FDA 483 | Frontage Laboratories, Inc. - Form 483, 2021-10-15 |
March, 2022 | FDA 483 | Elementis SRL, Inc. - Form 483, 2022-03-17 |
December, 2023 | FDA 483 | Granules Pharmaceuticals Inc. - Form 483, 2023-12-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more